Xiangling Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiangling Feng has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Baoshan Xu
Department of Minimally Invasive Spine Surgery, Tianjin Hospital, Tianjin University, Tianjin, China
1 shared publication - Bin Zhu
Cancer Research Institute, Collaborative Innovation Center for Cancer Medicine, Key Laboratory for Carcinogenesis of Chinese Ministry of Health, School of Basic Medical Science, Central South University, Changsha, People’s Republic of China
1 shared publication Bo Liu
1 shared publication- Caiping Ren
Cancer Research Institute, Xiangya School of Basic Medicine, Central South University, Changsha, China
1 shared publication - Chang Xian Zhang
Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France
1 shared publication - Chao Liu
Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou Guangdong China
1 shared publication
Latest Publications
- 8 July 2026
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 26, 1-20
Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets
Background: Glioma-Related Epilepsy (GRE) is a hallmark comorbidity of Low-Grade Glioma (LGG), yet the cellular and molecular mechanisms through which germline epilepsy susceptibility converges with tumor biology to shape clinical outcomes remain poorly understood. Methods: Genome-Wide Association Studies (GWAS), expression quantitative trait loci (eQTL) data, single-cell RNA sequencing, and spatial transcriptomics were integrated. Causal inference, phenotype-driven single-cell analyses, and machine learning were applied to identify genetically informed cellular mechanisms underlying GRE. Results: A total of 68 germline loci shared by glioma and epilepsy (FDRIVW < 0.05) were integrated, with microglia and excitatory neurons as the principal mediating cell types. Four seizure-associated genes (WFIKKN1, WDSUB1, SPARCL1, and CALD1) were subsequently identified in TCGA-LGG, with high-confidence enhancer-promoter support for three of them (colco.PP4 > 0.9). A four-gene signature consistently stratified overall survival across three independent cohorts (TCGA-LGG, CGGA_325, and GSE16011) and correlated with immune checkpoint gene expression. High-risk patients showed higher sensitivity to cyclopamine, according to in silico drug response. Discussion: These findings support a neuroimmune model in which pleiotropic germline variants act via microglia and excitatory neurons to link seizure biology with tumor immunity and prognosis. At the same time, in silico therapeutic predictions require functional and multi-ancestry validation. Conclusion: These results reveal a common genetic architecture between glioma and epilepsy, offering candidate biomarkers and therapeutic strategies for the management of GRE.
- 8 July 2026
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 26, 1-20
Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets
Background: Glioma-Related Epilepsy (GRE) is a hallmark comorbidity of Low-Grade Glioma (LGG), yet the cellular and molecular mechanisms through which germline epilepsy susceptibility converges with tumor biology to shape clinical outcomes remain poorly understood. Methods: Genome-Wide Association Studies (GWAS), expression quantitative trait loci (eQTL) data, single-cell RNA sequencing, and spatial transcriptomics were integrated. Causal inference, phenotype-driven single-cell analyses, and machine learning were applied to identify genetically informed cellular mechanisms underlying GRE. Results: A total of 68 germline loci shared by glioma and epilepsy (FDRIVW < 0.05) were integrated, with microglia and excitatory neurons as the principal mediating cell types. Four seizure-associated genes (WFIKKN1, WDSUB1, SPARCL1, and CALD1) were subsequently identified in TCGA-LGG, with high-confidence enhancer-promoter support for three of them (colco.PP4 > 0.9). A four-gene signature consistently stratified overall survival across three independent cohorts (TCGA-LGG, CGGA_325, and GSE16011) and correlated with immune checkpoint gene expression. High-risk patients showed higher sensitivity to cyclopamine, according to in silico drug response. Discussion: These findings support a neuroimmune model in which pleiotropic germline variants act via microglia and excitatory neurons to link seizure biology with tumor immunity and prognosis. At the same time, in silico therapeutic predictions require functional and multi-ancestry validation. Conclusion: These results reveal a common genetic architecture between glioma and epilepsy, offering candidate biomarkers and therapeutic strategies for the management of GRE.
- Open Access
- 1 January 2026
- Vol. 12 (1) , eady2539
Multidimensional mapping of stimulation-responsive regulatory elements and candidate causal variants in T cell activation.
Genome-wide association studies (GWASs) have elucidated numerous noncoding variants linked to immune-related disorders, yet the intricate context-specific mechanisms governing their effects remain poorly defined. Here, we leverage CD4+ T cell activation as a model to integrate multilayered genomic data and interrogate the dynamic regulatory mechanisms underpinning these genetic associations. We have applied a cistromic strategy to systematically identify and prioritize stimulation-responsive cis-regulatory elements (CREs) and key genes essential for T cell activation. Using capture Hi-C and tiling CRISPR activation screening at the CD28 locus, we reveal a pivotal CRE harboring a causal small insertion variant, rs5837875, that modulates CD28 activation in an allele-specific manner. Mechanistically, we demonstrate that ZNF384 mediates stimulation-responsive chromatin looping between the rs5837875-containing enhancer and the CD28 promoter, culminating in heightened CD28 expression and aberrant T cell hyperactivation. Our integrative and context-dependent strategy establishes a comprehensive pathway for deciphering the missing regulatory mechanisms of complex disease.
- 1 January 2026
- Vol. 12 (1) , eady2539
Open AccessMultidimensional mapping of stimulation-responsive regulatory elements and candidate causal variants in T cell activation.
Genome-wide association studies (GWASs) have elucidated numerous noncoding variants linked to immune-related disorders, yet the intricate context-specific mechanisms governing their effects remain poorly defined. Here, we leverage CD4+ T cell activation as a model to integrate multilayered genomic data and interrogate the dynamic regulatory mechanisms underpinning these genetic associations. We have applied a cistromic strategy to systematically identify and prioritize stimulation-responsive cis-regulatory elements (CREs) and key genes essential for T cell activation. Using capture Hi-C and tiling CRISPR activation screening at the CD28 locus, we reveal a pivotal CRE harboring a causal small insertion variant, rs5837875, that modulates CD28 activation in an allele-specific manner. Mechanistically, we demonstrate that ZNF384 mediates stimulation-responsive chromatin looping between the rs5837875-containing enhancer and the CD28 promoter, culminating in heightened CD28 expression and aberrant T cell hyperactivation. Our integrative and context-dependent strategy establishes a comprehensive pathway for deciphering the missing regulatory mechanisms of complex disease.
- Open Access
- 1 August 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-2
Author Correction: Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
- 1 August 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-2
Open AccessAuthor Correction: Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
- Open Access
- 3 April 2023
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (6) , e202201854
Dynamic changes of enhancer and super enhancer landscape in degenerated nucleus pulposus cells
Inflammatory cascade and extracellular matrix remodeling have been identified as pivotal pathological factors in the progression of intervertebral disc degeneration (IDD), but the mechanisms underlying the aberrant activation of transcription during nucleus pulposus (NP) cell degeneration remain elusive. Super-enhancers (SEs) are large clusters of adjacent lone enhancers, which control expression modes of cellular fate and pathogenic genes. Here, we showed that SEs underwent tremendous remodeling during NP cell degeneration and that SE-related transcripts were most abundant in inflammatory cascade and extracellular matrix remodeling processes. Inhibition of cyclin-dependent kinase 7, a transcriptional kinase–mediated transcriptional initiation in trans-acting SE complex, constricted the transcription of inflammatory cascades, and extracellular matrix remodeling–related genes such asIL1βandMMP3in NP cells, meanwhile, also restrained the transcription ofMmp16,Tnfrsf21, andIl11ra1to retard IDD in rats. In summary, our findings clarify SEs control the transcription of genes associated with inflammatory cascade and extracellular matrix remodeling during NP cell degeneration and identify inhibition of the cyclin-dependent kinase 7, required for SE-mediated transcriptional activation, as a therapeutic option for IDD.
- 3 April 2023
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (6) , e202201854
Open AccessDynamic changes of enhancer and super enhancer landscape in degenerated nucleus pulposus cells
Inflammatory cascade and extracellular matrix remodeling have been identified as pivotal pathological factors in the progression of intervertebral disc degeneration (IDD), but the mechanisms underlying the aberrant activation of transcription during nucleus pulposus (NP) cell degeneration remain elusive. Super-enhancers (SEs) are large clusters of adjacent lone enhancers, which control expression modes of cellular fate and pathogenic genes. Here, we showed that SEs underwent tremendous remodeling during NP cell degeneration and that SE-related transcripts were most abundant in inflammatory cascade and extracellular matrix remodeling processes. Inhibition of cyclin-dependent kinase 7, a transcriptional kinase–mediated transcriptional initiation in trans-acting SE complex, constricted the transcription of inflammatory cascades, and extracellular matrix remodeling–related genes such asIL1βandMMP3in NP cells, meanwhile, also restrained the transcription ofMmp16,Tnfrsf21, andIl11ra1to retard IDD in rats. In summary, our findings clarify SEs control the transcription of genes associated with inflammatory cascade and extracellular matrix remodeling during NP cell degeneration and identify inhibition of the cyclin-dependent kinase 7, required for SE-mediated transcriptional activation, as a therapeutic option for IDD.
- 4 July 2022
- Published by Springer Nature in The EMBO Journal
- Vol. 41 (16) , e110439
PGE2‐EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase
Brown adipose tissue (BAT) functions as a thermogenic organ and is negatively associated with cardiometabolic diseases. N6 -methyladenosine (m6 A) modulation regulates the fate of stem cells. Here, we show that the prostaglandin E2 (PGE2 )-E-prostanoid receptor 3 (EP3) axis was activated during mouse interscapular BAT development. Disruption of EP3 impaired the browning process during adipocyte differentiation from pre-adipocytes. Brown adipocyte-specific depletion of EP3 compromised interscapular BAT formation and aggravated high-fat diet-induced obesity and insulin resistance in vivo. Mechanistically, activation of EP3 stabilized the Zfp410 mRNA via WTAP-mediated m6 A modification, while knockdown of Zfp410 abolished the EP3-induced enhancement of brown adipogenesis. EP3 prevented ubiquitin-mediated degradation of WTAP by eliminating PKA-mediated ERK1/2 inhibition during brown adipocyte differentiation. Ablation of WTAP in brown adipocytes abrogated the protective effect of EP3 overexpression in high-fat diet-fed mice. Inhibition of EP3 also retarded human embryonic stem cell differentiation into mature brown adipocytes by reducing the WTAP levels. Thus, a conserved PGE2 -EP3 axis promotes BAT development by stabilizing WTAP/Zfp410 signaling in a PKA/ERK1/2-dependent manner.
- 4 July 2022
- Published by Springer Nature in The EMBO Journal
- Vol. 41 (16) , e110439
PGE2‐EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase
Brown adipose tissue (BAT) functions as a thermogenic organ and is negatively associated with cardiometabolic diseases. N6 -methyladenosine (m6 A) modulation regulates the fate of stem cells. Here, we show that the prostaglandin E2 (PGE2 )-E-prostanoid receptor 3 (EP3) axis was activated during mouse interscapular BAT development. Disruption of EP3 impaired the browning process during adipocyte differentiation from pre-adipocytes. Brown adipocyte-specific depletion of EP3 compromised interscapular BAT formation and aggravated high-fat diet-induced obesity and insulin resistance in vivo. Mechanistically, activation of EP3 stabilized the Zfp410 mRNA via WTAP-mediated m6 A modification, while knockdown of Zfp410 abolished the EP3-induced enhancement of brown adipogenesis. EP3 prevented ubiquitin-mediated degradation of WTAP by eliminating PKA-mediated ERK1/2 inhibition during brown adipocyte differentiation. Ablation of WTAP in brown adipocytes abrogated the protective effect of EP3 overexpression in high-fat diet-fed mice. Inhibition of EP3 also retarded human embryonic stem cell differentiation into mature brown adipocytes by reducing the WTAP levels. Thus, a conserved PGE2 -EP3 axis promotes BAT development by stabilizing WTAP/Zfp410 signaling in a PKA/ERK1/2-dependent manner.